On Mar. 25, 2026, Merck, and Terns Pharmaceuticals, a clinical-stage oncology company, announced that the companies have entered…
On Mar. 25, 2026, researchers, led by scientists at the University of Yamanashi in Japan, cloned a single…
On Mar. 24, 2026, researchers at the Francis Crick Institute report that the largest ancient DNA study of…
On Mar. 24, 2026, a study published in Nature describes how researchers are pulling clues from genetic material…
On Mar. 24, 2026, Governor Brian P. Kemp announced that global biopharmaceutical giant UCB, is planning a significant…
On Mar. 24, 2026, Pfizer and Valneva announced topline results from the Phase 3 VALOR “Vaccine Against Lyme…
On Mar. 23, 2026, it was reported that since the beginning of March, highly pathogenic avian influenza has…
On Mar. 20, 2026, Novartis announced an agreement with Synnovation Therapeutics, to acquire SNV4818, a pan-mutant‑selective PI3Kα inhibitor,…
On Mar. 20, 2026, the South China Morning Post reported that celebrated scientist Shu Xiaokun, Ph.D. leaves prestigious…
On Mar. 19, 2026, the University of Southern Denmark announced it has placed a “full hold” on a…
On Mar. 19, 2026, The U.S. Food and Drug Administration approved a 7.2-milligram dose of Danish drugmaker Novo…
On Mar. 19, 2026, a nationwide STAT survey of federally funded researchers reveals that, a year after Donald…
On Mar. 18, 2026, the National Institutes of Health (NIH) announced more than $150 million to develop and…
On Mar. 16, 2026, investigators from Mass General Brigham announce they have built metabolic polygenic risk scores (PRS) for predicting…
On Mar. 13, 2026, ImmunityBio announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a…
On Mar. 13, 2026, GSK announced that the US Food and Drug Administration (FDA) has expanded the approved…
On Mar. 12, 2026, scientists at the University of Cambridge announced they have developed a new way to…
On Mar. 12, 2026, Mass General Brigham (MGB) announced it has received a $50 million gift that will…
On Mar. 12, 2026, a team of researchers at the University of Southern California Mark and Mary Stevens…
On Mar. 11, 2026, taking a step towards developing genetic therapies at scale, researchers from Mass General Brigham…
On Mar. 11, 2026, the U.S. Food and Drug Administration (FDA) announced it is implementing the Adverse Event…
On Mar. 11, 2026, the tetravalent dengue vaccine, developed by the Butantan Institute in São Paulo, Brazil, with…
On Mar. 10, 2026, researchers from the University of California San Diego have found that a novel blood-based…
On Mar. 10, 2026, the World Health Organization (WHO) released landmark Consolidated guidance and implementation handbook on hepatitis…
On Mar. 8, 2026, a new statewide spatial analysis of Alzheimer’s disease and related dementias (ADRD) has uncovered…
On Mar. 6, 2026, Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has approved…
On Mar. 6, 2026, Sumitomo Pharma announce it has obtained conditional and time‑limited approval in Japan for the…
On Mar. 3, 2026, a Johns Hopkins university study shows major impacts could transport life between planets. Tiny…
On Feb. 27, 2026, the European Medicines Agency (EMA) announced it’s recommending marketing authorization for mCombriax, Moderna’s combined…
On Feb. 27, 2026, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved three…